Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05890404 · ClinicalTrials.gov registry record · NA
SGM Evidenced-Based Mental Healthcare Implementation
A NA study of LGBTQ and CBT, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,410
- Enrollment target
- 1
- Study location
NCT05890404 is a NA study of LGBTQ and CBT that is actively recruiting participants, run by Yale University. The registered enrollment target is 1,410 participants, above the 110-participant average among 3 other LGBTQ trials with a reported enrollment target (1182% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05890404, a NA study of LGBTQ and CBT, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,410 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the proposed study is to identify effective strategies for implementing lesbian, gay, bisexual, transgender, and queer (LGBTQ)- affirmative Cognitive-Behavioral Therapy (CBT) at LGBTQ community centers across the United States.
Interventions
- BEHAVIORAL LGBTQ-Affirmative CBT Training: Materials Only
- BEHAVIORAL LGBTQ-Affirmative CBT Training: Direct Training
- BEHAVIORAL LGBTQ-Affirmative CBT Training: Local Supervision
Study Locations (1)
New York
- Yale LGBTQ Mental Health Initiative with the Yale School of Public Office - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,410 participants |
| Start Date | 2024-02-08 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05890404
The ClinicalTrials.gov registry entry for NCT05890404 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,410 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 110-participant average among 3 other LGBTQ trials with a reported enrollment target (1182% higher). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with LGBTQ appearing as the primary indexed condition, and to 3 interventions - of which LGBTQ-Affirmative CBT Training: Materials Only is the first listed.
NCT05890404 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05890404 about?
NCT05890404 is a clinical study titled "SGM Evidenced-Based Mental Healthcare Implementation". The purpose of the proposed study is to identify effective strategies for implementing lesbian, gay, bisexual, transgender, and queer (LGBTQ)- affirmative Cognitive-Behavioral Therapy (CBT) at LGBTQ community centers across the United States.
What is the current status of trial NCT05890404?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,410 participants. The study started on 2024-02-08. Estimated completion is 2028-06-30.
What conditions does trial NCT05890404 study?
This clinical trial studies the following conditions: LGBTQ, CBT.
What interventions are being tested in trial NCT05890404?
The interventions under investigation include: LGBTQ-Affirmative CBT Training: Materials Only (BEHAVIORAL), LGBTQ-Affirmative CBT Training: Direct Training (BEHAVIORAL), LGBTQ-Affirmative CBT Training: Local Supervision (BEHAVIORAL).
Who is sponsoring clinical trial NCT05890404?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05890404 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for LGBTQ
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.